Evidence map›Paper›PMID 38529687›Full record

Trial reportCancer medicine2024

The feasibility and acceptability of an app-based intervention with brief behavioural support (APPROACH) to promote brisk walking in people diagnosed with breast, prostate and colorectal cancer in the UK.

Phillippa Lally, Fiona Kennedy, Susan Smith, Rebecca J Beeken, Caroline Buck, Chloe Thomas, Nicholas Counsell, Lynda Wyld, Charlene Martin, Sarah Williams and 7 more

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Phillippa LallyDepartment of Psychological Sciences, University of Surrey, Guildford, Surrey, UK.
Fiona KennedyLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.ORCID 0000-0002-4910-2505
Susan SmithDepartment of Behavioural Science and Health, University College London, London, UK.ORCID 0000-0002-0193-0328
Rebecca J BeekenLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Caroline BuckDepartment of Behavioural Science and Health, University College London, London, UK.
Chloe ThomasSchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-8704-3262
Nicholas CounsellCancer Research UK & Cancer Trials Centre, Cancer Institute, University College London, London, UK.
Lynda WyldDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Charlene MartinDepartment of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Sarah WilliamsDepartment of Behavioural Science and Health, University College London, London, UK.
Anna RobertsDepartment of Behavioural Science and Health, University College London, London, UK.
Diana M GreenfieldSheffield Teaching Hospitals NHS FT, Weston Park Hospital, Sheffield, UK.
Jacqui GathIndependent Cancer Patients' Voice (ICPV), London, UK.
Henry W W PottsInstitute of Health Informatics, University College London, London, UK.
Nicholas LatimerSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
Lee SmithThe Centre for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.
Abi FisherDepartment of Behavioural Science and Health, University College London, London, UK.
University College London · GBUniversity of Sheffield · GBUniversity of Leeds · GBAnglia Ruskin University · GBCancer Research UK · GBThe Patients Association · GBUniversity of Surrey · GBWeston Park Cancer Centre · GB

Funding

Yorkshire Cancer Research RA/2018/R1/005
6 · The paper itself

Abstract

introductionIncreased moderate to vigorous physical activity (MVPA) can improve clinical and psychosocial outcomes for people living with and beyond cancer (LWBC). This study aimed to assess the feasibility and acceptability of trial procedures in a pilot randomised controlled trial (RCT) of a theory-driven app-based intervention with behavioural support focused on promoting brisk walking (a form of MVPA) in people LWBC (APPROACH).

methodsParticipants diagnosed with breast, prostate or colorectal cancer were recruited from a single UK hospital site. Assessments at baseline and 3 months included online questionnaires, device-measured brisk walking (activPAL accelerometer) and self-reported weight and height. Participants were randomised to intervention or control (care as usual). The intervention comprised a non-cancer-specific app to promote brisk walking (National Health Service 'Active 10') augmented with print information about habit formation, a walking planner and two behavioural support telephone calls. Feasibility and acceptability of trial procedures were explored. Initial estimates for physical activity informed a power calculation for a phase III RCT. A preliminary health economics analysis was conducted.

resultsOf those medically eligible, 369/577 (64%) were willing to answer further eligibility questions and 90/148 (61%) of those eligible were enrolled. Feasibility outcomes, including retention (97%), assessment completion rates (>86%) and app download rates in the intervention group (96%), suggest that the trial procedures are acceptable and that the intervention is feasible. The phase III RCT will require 472 participants to be randomised. As expected, the preliminary health economic analyses indicate a high level of uncertainty around the cost-effectiveness of the intervention.

conclusionsThis pilot study demonstrates that a large trial of the brisk walking intervention with behavioural support is both feasible and acceptable to people LWBC. The results support progression onto a confirmatory phase III trial to determine the efficacy and cost-effectiveness of the intervention.

Indexed as

Colorectal NeoplasmsMobile ApplicationsFeasibility StudiesHumansMaleProstateUnited KingdomWalkingbrisk walkingcancer survivorshabitsmobile appsphysical activitypilot study

Identifiers

PMID38529687
PMCPMC10964176
OpenAlexW4393204758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.